Cargando…

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis

Normalizing bone metabolism is a challenge in rheumatoid arthritis (RA). Studies in mice suggest that anti-citrullinated protein antibodies (ACPAs) can trigger osteoclast activation and bone resorption in the bone marrow. However, data on the presence and role of ACPAs in human bone marrow are scarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurowska, Weronika, Slowinska, Iwona, Krogulec, Zbigniew, Syrowka, Piotr, Maslinski, Wlodzimierz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073027/ https://www.ncbi.nlm.nih.gov/pubmed/33921836 http://dx.doi.org/10.3390/jcm10081778

Ejemplares similares

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2017)

Different expression of chemokines in rheumatoid arthritis and osteoarthritis bone marrow
por: Kuca-Warnawin, Ewa H., et al.
Publicado: (2016)

Rheumatoid arthritis bone marrow environment supports Th17 response
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2017)

Significance of bone marrow edema in pathogenesis of rheumatoid arthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

CD4(+)FOXP3(+) T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired
por: Massalska, Magdalena, et al.
Publicado: (2020)

Implication of the Association of Fibrinogen Citrullination and Osteoclastogenesis in Bone Destruction in Rheumatoid Arthritis
por: Kim, Ji Soo, et al.
Publicado: (2020)

Cartilage and bone damage in rheumatoid arthritis
por: Ostrowska, Monika, et al.
Publicado: (2018)

New evidence for a role of bone marrow in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2016)

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development
por: Kurowska, Weronika, et al.
Publicado: (2020)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
por: Avdeeva, A. S., et al.
Publicado: (2014)

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint
por: Smiljanovic, Biljana, et al.
Publicado: (2018)

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2023)

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study
por: Kurowska, Weronika, et al.
Publicado: (2018)

Bone marrow as a secondary lymphoid organ: mature T-cell subsets in bone marrow from rheumatoid arthritis and osteoarthritis patients
por: Warnawin, E, et al.
Publicado: (2005)

HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis
por: Balandraud, Nathalie, et al.
Publicado: (2013)

Unbalanced levels of bone resorption promoting factors in bone marrow from patients with rheumatoid arthritis in comparison to osteoarthritis
por: Maslinski, W, et al.
Publicado: (2003)

Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis
por: Ohmura, Koichiro, et al.
Publicado: (2010)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures
por: Stemmler, Fabian, et al.
Publicado: (2018)

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis
por: Sakkas, Lazaros I., et al.
Publicado: (2017)

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2014)

Distinct lymphocyte subpopulations in bone marrow from rheumatoid arthritis and osteoarthritis patients: a role for IL-15?
por: Maslinski, W, et al.
Publicado: (2004)

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis
por: Paulissen, Sandra M. J., et al.
Publicado: (2015)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

Roles of MicroRNAs in Bone Destruction of Rheumatoid Arthritis
por: Zhao, Hanxiao, et al.
Publicado: (2020)

The role of dendritic cells derived osteoclasts in bone destruction diseases
por: Wang, Bo, et al.
Publicado: (2020)

Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis
por: Yudoh, Kazuo, et al.
Publicado: (2009)

Shared Epitope Alleles Remain A Risk Factor for Anti-Citrullinated Proteins Antibody (ACPA) – Positive Rheumatoid Arthritis in Three Asian Ethnic Groups
por: Chun-Lai, Too, et al.
Publicado: (2011)

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
por: Padyukov, Leonid, et al.
Publicado: (2010)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
por: Xu, Minjie, et al.
Publicado: (2023)

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
por: Cunningham, Kevin Y., et al.
Publicado: (2023)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
por: Steffen, Ulrike, et al.
Publicado: (2019)

The P. gingivalis Autocitrullinome Is Not a Target for ACPA in Early Rheumatoid Arthritis
por: Muñoz-Atienza, E., et al.
Publicado: (2020)

ACPA Status Correlates with Differential Immune Profile in Patients with Rheumatoid Arthritis
por: Floudas, Achilleas, et al.
Publicado: (2021)

ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation
por: Li, Ketian, et al.
Publicado: (2022)

The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis
por: Shafrin, Jason, et al.
Publicado: (2018)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial
por: Seegobin, Seth D, et al.
Publicado: (2014)

High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
por: Gomez-Cabrero, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_daofastk3v9end7nu55o6s23mg